News Focus
News Focus
icon url

XenaLives

12/28/18 5:35 PM

#176578 RE: OFP #176569

Your argument as I understand it:

Ignore the clinical and preclinical studies showing AVXL 2-73 to be more effective than the S1 agonists already on the market and worry that all of those studies are meaningless....